Tony Yen

Product Development Manager ＠ Illumina

Tony Yen, PhD, is an accomplished technical leader and systems integration expert with over a decade of experience in product development across established corporations, startups, and academic laboratories. Currently serving as a Staff Systems Integration Scientist at Illumina, Inc., Tony has played a pivotal role in the development and launch of groundbreaking DNA sequencing platforms, including the NovaSeq X and iSeq100. His integration expertise spans various subsystem types, including optics, informatics, fluidics, motion, and thermal systems, enabling him to deliver best-in-class performance across throughput spaces of DNA sequencing. Tony’s contributions have led to significant advancements in the field, such as enabling unprecedented pricing at $200 per human genome and driving further demand elasticity for the NGS market. With a PhD in Bioengineering from the University of California, San Diego, and an MBA in progress, Tony combines his technical prowess with business acumen to drive operational excellence and innovation in the genomics industry.

Debbie Lin

Vice President @ Caris Life Sciences and Venture Partner @ T.Rx Capital

Dr. Debbie Lin has over 20+ years of business leadership experience in multinational environments, having lived and worked in global executive positions in the US, Europe and Asia. Debbie’s forte is new business model strategy, business development, venture capital in healthcare and medtech with a focus on scientific product development, value proposition refinement, and market access.

As Executive Director for Boehringer Ingelheim Venture Fund, Debbie was accountable for digital
health investments, board directorship and digital health strategy setting in North America. Previous to her role at the Venture Fund, she was Global Director of Corporate Development where
she crafted new business models for healthcare in major global markets.

She has also held operational roles in field based Health Economics and Medical Affairs working
with national payers, regional providers and opinion leaders. She supported more than 5 drug launches and a variety of disease indications. Debbie is an Adjunct Faculty Advisor at UCLA Anderson School of Business and a mentor at Stanford MedicineX. She currently in VP of Strategic Partnerships at Caris Life Sciences, a precision oncology diagnostics company and a Venture partner at T.Rx Capital.

Eddie Chung

CEO @ Coastar Therapeutics

Mr. Chung has extensive experience in the drug delivery industry, with a strong track record of managing projects from R&D to IND package preparation. He serves on the board of several organizations and has been the CEO of Coastar for the past four years. Mr. Chung holds an MS degree in Bioengineering from UC San Diego and a BS degree from National Tsinghua University.